Fundz

Brainstorm Cell Therapeutics Inc. reported raising in an initial SEC Form D filing

PUBLIC · BCLIJun 20, 2018

Round Type

Venture

New YorkBiotechnologyHealth CareTherapeuticsresearch

Quick answer

Brainstorm Cell Therapeutics raised an undisclosed amount in a funding round, dated June 20, 2018. Brainstorm Cell Therapeutics is based in New York, New York, United States.

How much did Brainstorm Cell Therapeutics raise?
Brainstorm Cell Therapeutics raised an undisclosed amount in a funding round on June 20, 2018.
What does Brainstorm Cell Therapeutics do?
BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) is a leading developer of autologous adult stem cell therapies for debilitating neurodegenerative diseases.
Where is Brainstorm Cell Therapeutics based and how big is it?
Brainstorm Cell Therapeutics is based in New York, New York, United States. Fundz records about 27 employees.
Who are the decision-makers at Brainstorm Cell Therapeutics?
Fundz holds 1 contact at Brainstorm Cell Therapeutics, including the Chief Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and research around the same time

Companies in the same sectors as Brainstorm Cell Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Akouos, Inc. raised $25M on August 1, 2018.
  • Windtree Therapeutics raised $1.5M (Seed) on July 25, 2018.
  • BehaVR raised $500K (Seed) on July 25, 2018.
  • Alpha Cognition raised $2M (Seed) on July 20, 2018.
  • Pliant Therapeutics raised an undisclosed amount on July 20, 2018.
  • AiVita Biomedical, Inc. raised $17M on July 20, 2018.

Who to call at Brainstorm Cell Therapeutics, and when

A new round usually means Brainstorm Cell Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Brainstorm Cell Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Brainstorm Cell Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Brainstorm Cell Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Brainstorm Cell Therapeutics

Location

1325 Avenue of Americas, 28th Floor

New York, New York, United States

About

BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) is a leading developer of autologous adult stem cell therapies for debilitating neurodegenerative diseases. The company's proprietary NurOwn® platform uses autologous mesenchymal stem cells (MSCs) to produce neurotrophic factor-secreting cells (MSC-NTF cells), designed to deliver targeted biological signals that modulate neuroinflammation and promote neuroprotection.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Brainstorm Cell Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsChaim L., Chief Executive Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Brainstorm Cell Therapeutics's next move

See what Strategic adds

Brainstorm Cell Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.